Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington’s disease-Reference-Cited by-同舟云学术

Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington’s disease

Published:2014-02-10 Issue:7 Volume:22 Page:931-939
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Bhatt Rahul,Singh Devendra,Prakash Atish,Mishra Neeraj

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10717544.2014.880860

Reference41 articles.

1. Experimental therapeutics in transgenic mouse models of Huntington's disease

2. In Vivo Calpain/Caspase Cross-talk during 3-Nitropropionic Acid-induced Striatal Degeneration

3. A review of the treatment options for Huntington’s disease

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in nanotherapeutic strategies for Huntington's disease: Design, delivery, and neuroprotective mechanisms;Coordination Chemistry Reviews;2025-01

2. Nanotechnology-driven Microemulsion Based Intranasal Delivery to Neurotechnology-driven Neuralink: Strategies to Improve Management of Neurodegenerative Disorders;AAPS PharmSciTech;2024-09-12

3. Application of Casein Micelles for Targeting Huntington’s Disease in Experimental Zebrafish Model;Molecular Neurobiology;2024-07-31

4. Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration;ACS Chemical Neuroscience;2024-07-12

5. Construction and Evaluation of BAL-PTX Co-Loaded Lipid Nanosystem for Promoting the Anti-Lung Cancer Efficacy of Paclitaxel and Reducing the Toxicity of Chemotherapeutic Drugs;International Journal of Nanomedicine;2024-07